- Type / Class
- Equity / COM NEW
- Total 13F shares
- 2,559,014
- Share change
- +201,965
- Total reported value
- $1,109,942
- Put/Call ratio
- 2.8%
- Price per share
- $0.43
- Number of holders
- 24
- Value change
- +$92,789
- Number of buys
- 8
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP 45408X308?
CUSIP 45408X308 identifies IGC - IGC Pharma, Inc. - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45408X308:
Top shareholders of IGC - IGC Pharma, Inc. - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857) |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
13,823,529
|
$4,700,000 | — | 22 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
—
class O/S missing
|
715,440
|
$286,176 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
—
class O/S missing
|
645,166
|
$258,067 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
324,296
|
$129,760 | — | 31 Mar 2024 | |
| Rohit Goel |
3/4/5
|
Senior Director of Finance&PAO |
—
class O/S missing
|
235,000
|
$79,900 | — | 13 May 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
—
class O/S missing
|
141,303
|
$57,000 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
—
class O/S missing
|
119,707
|
$47,883 | — | 31 Mar 2024 | |
| DEARBORN PARTNERS LLC |
13F
|
Company |
—
class O/S missing
|
116,710
|
$46,684 | — | 31 Mar 2024 | |
| John E. Lynch |
3/4/5
|
Director |
—
mixed-class rows
|
396,901
mixed-class rows
|
$45,696 | — | 31 May 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
—
class O/S missing
|
71,364
|
$28,546 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
—
class O/S missing
|
65,495
|
$26,198 | — | 31 Mar 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
—
class O/S missing
|
37,306
|
$14,922 | — | 31 Mar 2024 | |
| TRUIST FINANCIAL CORP |
13F
|
Company |
—
class O/S missing
|
36,667
|
$14,667 | — | 31 Mar 2024 | |
| XTX Topco Ltd |
13F
|
Company |
—
class O/S missing
|
29,272
|
$11,709 | — | 31 Mar 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
—
class O/S missing
|
16,437
|
$6,575 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
—
class O/S missing
|
14,576
|
$5,830 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
13,654
|
$5,462 | — | 31 Mar 2024 | |
| Geneos Wealth Management Inc. |
13F
|
Company |
—
class O/S missing
|
3,000
|
$1,200 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
—
class O/S missing
|
2,751
|
$1,100 | — | 31 Mar 2024 | |
| CENTRAL TRUST Co |
13F
|
Company |
—
class O/S missing
|
900
|
$360 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
—
class O/S missing
|
860
|
$344 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
—
class O/S missing
|
800
|
$320 | — | 31 Mar 2024 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
—
class O/S missing
|
655
|
$312 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
—
class O/S missing
|
379
|
$152 | — | 31 Mar 2024 | |
| Caitlin John, LLC |
13F
|
Company |
—
class O/S missing
|
200
|
$80 | — | 31 Mar 2024 | |
| DHJJ Financial Advisors, Ltd. |
13F
|
Company |
—
class O/S missing
|
80
|
$32 | — | 31 Mar 2024 | |
| NewEdge Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
25
|
$10 | — | 31 Mar 2024 | |
| TORONTO DOMINION BANK |
13F
|
Company |
—
class O/S missing
|
6
|
$2 | — | 31 Mar 2024 |
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2024
As of 30 Jun 2024,
IGC Pharma, Inc. - COM NEW (IGC) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,559,014 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, DEARBORN PARTNERS LLC, NORTHERN TRUST CORP, GOLDMAN SACHS GROUP INC, Virtu Financial LLC, and TRUIST FINANCIAL CORP.
This page lists
24
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
25
Q2 2024 holders
24
Holder diff
-1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.